Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

Data as of Jan 27
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company. It is focused on developing new pharmaceutical products that are safer and more effective than widely prescribed central nervous system drugs in large and growing markets. It products include TNX-102 SL and TNX-102 SL. Tonix Pharmaceuticals Holding was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.

Contact Information

Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue
New York New York 10022
P:(212) 980-9155
Investor Relations:



Individual stakeholders7.39%
Mutual fund holders7.05%
Other institutional18.19%

Top Executives

Seth LedermanChairman, President & Chief Executive Officer
Leland J. GershellChief Financial Officer & Treasurer
Gregory M. SullivanChief Medical Officer
Bruce L. DaughertySecretary, Chief Scientific Officer & Controller
Jessica E. EdgarSenior Vice President-Finance

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.